TY  - GEN
AU  - Ramcharan,Roger
AU  - Aleksic,Tamara
AU  - Kamdoum,Wilfride Petnga
AU  - Gao,Shan
AU  - Pfister,Sophia X
AU  - Tanner,Jordan
AU  - Bridges,Esther
AU  - Asher,Ruth
AU  - Watson,Amanda J
AU  - Margison,Geoffrey P
AU  - Woodcock,Mick
AU  - Repapi,Emmanouela
AU  - Li,Ji-Liang
AU  - Middleton,Mark R
AU  - Macaulay,Valentine M
TI  - IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
SN  - 1949-2553
PY  - 2016///0920
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - DNA Breaks, Double-Stranded
KW  - Dacarbazine
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - G1 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - Imidazoles
KW  - Melanoma
KW  - drug therapy
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Mutation
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Pyrazines
KW  - Receptor, IGF Type 1
KW  - antagonists & inhibitors
KW  - Survival Analysis
KW  - Temozolomide
KW  - Tumor Suppressor Protein p53
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.5631
ER  -